Zenith Drugs Ltd

NSE: ZENITHDRUG · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹42.15
Market cap: ₹72.28 Cr
Revenue (annual): ₹171.2 Cr
Net profit (annual): ₹3.94 Cr
P/E (TTM): 18.3×Sector 47.4×
Promoter holding: 69.98%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All New Order Win 5 Annual General Meeting 4 Capital Structure Change 3 Other Announcement 2 Financial Results 2 Capacity Expansion 2 Results Correction 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

26 Aug 2026 13:10 IST NSE

Capital Structure Change

Zenith Drugs Capital Structure Change

Zenith Drugs Limited's board approved the allotment of 16,09,050 convertible warrants to promoters on a preferential basis. The aggregate consideration for this issuance is Rs. 6.99 Crore.

Value: ₹7.00 Cr

Read the filing ↗

26 Jun 2026 18:43 IST NSE

Capital Structure Change

Zenith Drugs Capital Structure Change

Zenith Drugs approved a Rs. 7 Crore preferential issue of convertible warrants. The warrants are exercisable into equity shares within 18 months.

Value: ₹7.00 Cr
Execution: 18 months

Read the filing ↗

26 Jun 2026 18:25 IST NSE

Capital Structure Change

Zenith Drugs Capital Structure Change

Zenith Drugs approved issuing 16,09,050 warrants to promoters for ₹6.99 Crore. The preferential issue is subject to shareholder and regulatory approval.

Value: ₹6.99 Cr

Read the filing ↗